371: Dementia Headlines: Fact or Fiction?

Full analysis

Dementia care expert Teepa Snow and host Greg Phelps work through a stack of real clickbait headlines — "32% lower Alzheimer's risk from this drink," "95% of Alzheimer's is lifestyle," "exercise grows brain cells by 50%" — and call out what is false, what is grossly overstated, and what is simply noise. The core message: dementia is multifactorial, no single food or habit causes or prevents it, and chasing headlines leaves care partners frightened and self-blaming rather than better equipped.

What was covered

• The headline parade. Host Greg Phelps read roughly a quarter of the dementia-related clickbait headlines he collected from the first six months of the year — percentages ranging from 18% lower risk (coffee) to 600% higher risk, claims about foods, drinks, exercises, Japanese devices, and VapoRub.
• Flat rejection of the "95% lifestyle" claim. Teepa Snow said flatly that the headline claiming 95% of Alzheimer's cases are caused by lifestyle is "totally inaccurate" and "not true," and that she is familiar with the major research databases and none would support that figure.
• Multifactorial framing. Snow explained that current scientific thinking holds that dementia — whether Alzheimer's, Lewy body, or frontotemporal — results from many interacting factors in a cascade sequence, not a single trigger that a single intervention can reverse.
• Neuroplasticity is real but not a cure. Snow acknowledged that neuroplasticity — the brain's ongoing capacity to form new connections — is genuine and present even in people living with dementia. She used it to gently undercut headlines implying that "growing new brain cells" through one exercise or food is a meaningful treatment claim.
• Drug treatments for amyloid plaques. Snow briefly addressed the expensive treatments now available in the U.S. that reduce beta-amyloid buildup in the brain, noting that newer research points to tau protein formations as more predictive of symptoms, and expressing skepticism — shared by some researchers — about whether amyloid-clearing is "worth a whole lot."
• The blame burden on care partners. Snow argued that sensationalized headlines don't just mislead — they make care partners feel guilty, as if they caused the disease by allowing certain foods or habits, or failed to prevent it. She called on listeners to stop that cycle.

Notable claims & predictions

• Teepa Snow on the 95% lifestyle headline: "95% of Alzheimer's is not lifestyle. That is totally inaccurate. I don't know where that headline came from, but it's not accurate. It's not true. I'm pretty familiar with all of them [the major databases]. None of them would put up 95%."
• Snow on the multifactorial nature of dementia: "The current thinking, really, for people who do know what they're doing, is it's multifactorial — there's lots of things that go into it, and that's a cascade event."
• Snow on amyloid-clearing drugs: "Even if I reduce the beta amyloid, what does that mean? Because the latest studies say more tau formations are the ones that are really going to matter for symptoms. And we're not exactly sure in most cases if it's worth a whole lot."
• Snow's practical rule for cutting through the noise: "Look at what's good for your heart because it's probably good for your brain. But if you're looking for magic, try training."
• Snow on algorithmic rabbit holes: "As long as people are looking for an answer like that…they'll quit putting that crap out. Quit looking for the magic."
• Snow to care partners: "Let it go. Quit looking for the magic, and don't blame carers for 'I let her do this' or 'I told him to do this, and now he's still…' Let it go."

Fact check

Claim (Snow): "95% of Alzheimer's is lifestyle" is "totally inaccurate." Snow's pushback is well-grounded. No major scientific consensus or large database study puts lifestyle factors at 95% causation. The most widely cited estimate — from the Lancet Commission on dementia prevention — attributes roughly 40–45% of dementia cases to modifiable risk factors across the lifespan. The 95% figure, as Snow says, has no credible source. Her call-out is accurate.

Claim (implicit in headlines, not challenged by Snow): specific percentage-risk figures (32% lower, 28% lower, 63% higher, etc.). Snow doesn't walk through the individual studies behind each headline, so they go largely unexamined in the episode. These percentages are a standard feature of observational nutrition studies: they typically reflect relative risk reductions in a single population over a defined period, not absolute risk, and most are not replication-ready. Listeners should treat any single-digit or double-digit percentage attached to one food or drink as almost certainly overstated when stripped of study size, duration, and confounders. The episode flags this general problem but doesn't drill into individual claims.

Claim (Snow): "Latest studies say more tau formations are the ones that are really going to matter for symptoms." This is a fair characterization of a genuine and active scientific debate. The field has increasingly focused on tau pathology as a closer correlate of cognitive symptoms than amyloid burden. Snow presents it as more settled than the research currently is — it remains contested — but she is accurately reflecting a meaningful shift in scientific emphasis. Characterize this as a reasonable summary of a live debate, not a settled fact.

Claim about coffee: The 18% lower dementia risk figure for coffee drinkers was raised as a headline, not as a validated finding, and Snow did not endorse it — she used it to illustrate confirmation bias (we accept the claims that fit what we already do). That's a fair point, not a health recommendation.

Why this matters for you

• If you are a care partner, Snow's direct message is that you did not cause this disease by what you did or didn't do — and that guilt-driven headline-chasing is more likely to exhaust you than help the person you're caring for. That reframe has real psychological value worth holding onto.
• If you are managing your own brain-health anxiety, the episode offers a useful filter: single-ingredient, single-percentage claims about dementia risk are almost always observational, context-stripped, and not actionable. A general rule Snow endorses — what is good for cardiovascular health is likely good for brain health — is more durable guidance than any specific headline.
• If you or a family member is considering or already on an amyloid-clearing drug (such as lecanemab or donanemab, now available in the U.S.), Snow's skepticism about their real-world benefit and the emerging emphasis on tau as a better disease marker is worth raising with a neurologist. It is not a reason to refuse treatment, but it is a reason to ask pointed questions about what the drug is expected to accomplish.
• On substance, this episode is more corrective than instructive — it debunks without replacing the bad headlines with a detailed positive framework. If you are looking for specific, evidence-grounded dementia prevention guidance, this episode alone won't provide it; it clears the field without fully planting it.